ASCO Steering Group on Cancer Care Delivery and Research in a Post-Pandemic Environment

ASCO established a Steering Group to guide ASCO’s Road to Recovery initiative. The Steering Group will assess major impacts of the COVID-19 pandemic on cancer care delivery, practice health, and clinical research, and provide recommendations on the operational and policy strategies necessary to sustain progress in clinical cancer research and ensure access to high-quality cancer during and after the pandemic. The Steering Group is composed of two task forces: one focused on cancer research and one focused on cancer care delivery issues.

Leadership Group

• Howard A. “Skip” Burris, III, MD, FACP, FASCO, Sarah Cannon Research Institute
• Nathan A. Pennell, MD, PhD, FASCO, Cleveland Clinic
• Melissa S. Dillmon, MD, FASCO, Harbin Clinic LLC
• Richard L. Schilsky, MD, FACP, FSCT, FASCO, American Society of Clinical Oncology
• Stephen S. Grubbs, MD, FASCO, American Society of Clinical Oncology
• Deborah Y. Kamin, RN, PhD, American Society of Clinical Oncology

Task Force on Cancer Research

• Nathan A. Pennell, MD, PhD, FASCO, Cleveland Clinic
• Kathryn Finch Mileham, MD, FACP, Levine Cancer Institute, Atrium Health
• Allison Magnuson, DO, University of Rochester
• Lynn Matrisian, PhD, MBA, Pancreatic Cancer Action Network
• Grzegorz (Greg) S. Nowakowski, MD, Mayo Clinic
• Ramya Thota, MBBS, Intermountain Healthcare
• Ajjai S. Alva, MD, University of Michigan
• Timothy L. Cannon, MD, INOVA Medical Group
• Jane Perlmutter, PhD, MBA, Gemini Group
• Jonathan M. Marron, MD, MPH, FAAP, Boston Children’s Hospital
• Maximilian Diehn, MD, PhD, Stanford University
• Tari A. King, MD, Dana-Farber/Brigham and Women's Cancer Center
• Gladys Rodriguez, MD, START Center for Cancer Care
• Manali I. Patel, MD, Stanford University
• Mithat Gönen, PhD, Memorial Sloan Kettering Cancer Center
• Connie M. Szczepanek, RN, BSN, CCRP, Cancer Research Consortium of West Michigan NCORP
• Eleonora Teplinsky, MD, Valley Health System

Task Force on Cancer Care Delivery

• Melissa S. Dillmon, MD, FASCO, Harbin Clinic LLC
• Piyush Srivastava, MD, Kaiser Permanente, Northern California
• Robin Zon, MD, FACP, FASCO, Michiana Hematology Oncology
• Natalie R. Dickson, MD, MMHC, FACP, Tennessee Oncology
• Jack O. Hensold, MD, Bozeman Deaconess Health Services
• Todd A. Pickard, PA-C, FASCO, University of Texas MD Anderson Cancer Center
• Maria Gonzalez, MPH, Virginia Mason Medical Center
• Theresa M. McDonnell, APRN-BC, DNP, Seattle Cancer Care Alliance
• Shelley Fuld Nasso, MPP, National Coalition for Cancer Survivorship
• Barry Russo, MBA, The Center for Cancer and Blood Disorders
• Debra A. Patt, MD, MPH, MBA, FASCO, Texas Oncology PA
• Barbara L. McAneny, MD, MACP, FASCO, New Mexico Oncology Hematology Consultants, Ltd
• Sibel Blau, MD, Northwest Medical Specialties
• Kurt R. Oettel, MD, MBA, FACP, Gundersen Health System
• Carole K. Tremonti, CCRP, MBA, RN, Dana-Farber Cancer Institute
• Tiffany A. Traina, MD, Memorial Sloan Kettering Cancer Center
• Leslie J. Hinyard, PhD, MSW, Saint Louis University
• Abby R. Rosenberg, MD, MS, MA, FAAP, Seattle Children’s
• Cardinale B. Smith, MD, PhD, Icahn School of Medicine at Mount Sinai

COVID-19 Research and Analysis Steering Group

ASCO’s COVID-19 Research and Analysis Steering Group was established to provide guidance and expertise on ASCO’s array of COVID-19 data collection and analysis activities and CancerLinQ’s secondary research activities relating to COVID-19. In particular, the Steering Group will provide oversight of the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) and CancerLinQ Discovery research projects related to COVID-19.

• Otis Brawley, MD, MACP, FASCO, Johns Hopkins University
• Deborah Schrag, MD, MPH, FASCO, Dana-Farber Cancer Institute
• Charu Aggarwal, MD, MPH, University of Pennsylvania
• Nancy N. Baxter, MD, Cancer Care Ontario
• Elwyn C. Cabebe, MD, Stanford Cancer Center South Bay
• Ronald C. Chen, MD, MPH, FASCO, University of Kansas
• Abdul-Rahman Jazieh, MD, MPH, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center
• Jennifer C. King, PhD, GO₂ Foundation for Lung Cancer
• Dax Kurbegov, MD, Sarah Cannon Research Institute
• Randall A. Oyer, MD, Penn Medicine Lancaster General Health - Ann B. Barshinger Cancer Institute 
• Electra D. Paskett, PhD, Ohio State University
• Lisa C. Richardson, MD, MPH, Centers for Disease Control and Prevention
• Gabrielle Rocque, MD, MSPH, FASCO, University of Alabama
• Trevor Royce, MD, MPH, Lineberger Comprehensive Cancer Center, UNC
• Keith Sigel, MD, PhD, Icahn School of Medicine at Mount Sinai
• Alexander I. Spira, MD, PhD, FACP, Virginia Cancer Specialists PC
• K. Robin Yabroff, PhD, American Cancer Society